Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 32Leiomyoma 9Menorrhagia 5Prostate Adenocarcinoma 2Myofibroma 2Endometriosis 2Adenocarcinoma 2Pathologic Complete Response 1Neoplasm, Residual 1Neoplasm Metastasis 1Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1Metastatic Castration-Resistant Prostate Cancer 1Hormone Treatment-naïve Participants With Prostate Cancer 1

Interventions

relugolix 2vilaprisan 1cetrorelix 1Triptorelin Pamoate 1Transcranial Direct Current Stimulation 1Sutures 1Surgical Instruments 1Rocuronium 1Robotic Surgical Procedures 1Radiotherapy 1Radiation 1Menotropins 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Indocyanine Green 1Immunonutrition Diet 1Hysterectomy 1Gonadotropins 1Gonadotropin-Releasing Hormone 1Fluconazole 1Endoscopes 1Electrocoagulation 1Danazol 1Chorionic Gonadotropin 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Endometriosis × relugolix × Clear all
NCT05862272 2025-08-06

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Sumitomo Pharma Switzerland GmbH

Phase 3 Recruiting
1,000 enrolled

Endometriosis, Leiomyoma, Myofibroma

NCT02093390 2016-06-06

A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects

Millennium Pharmaceuticals, Inc.

Phase 1 Completed
40 enrolled 23 charts
Genitourinary

Endometriosis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡